Stay updated on CP-690,550 Dose Comparison in RA Clinical Trial
Sign up to get notified when there's something new on the CP-690,550 Dose Comparison in RA Clinical Trial page.

Latest updates to the CP-690,550 Dose Comparison in RA Clinical Trial page
- CheckyesterdayChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.5%
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
- Check23 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.5%
- Check44 days agoChange DetectedThe web page has removed a specific citation regarding a study on Creatine Kinase levels in Tofacitinib-treated patients with Ulcerative Colitis, including an erratum reference.SummaryDifference0.1%
Stay in the know with updates to CP-690,550 Dose Comparison in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CP-690,550 Dose Comparison in RA Clinical Trial page.